Amino Acids (AA)

C-Peptide is a monoclonal antibody that binds to the β-cell and inhibits insulin release. It has been used in diagnosis of type 1 diabetes mellitus. C-Peptide is a hormone that regulates blood glucose levels by controlling the rate of glucose production in the liver, as well as by inhibiting the breakdown of glycogen in the liver. The C-terminal amino acid sequence Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu -Leu-Gly can be cleaved from the peptide by trifluoroacetic acid to yield free Gln, which can then be detected using mass spectrometry. Growth factors such as IGF1, FGF21, and HGF have been shown to increase C peptide levels in diabetic patients.

Please enquire for more information about Mca-(Asn670,Leu671)-Amyloid beta/A4 Protein Precursor770 (669-674)-Lys(Dnp) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Teicoplanin is an amide-linked glycopeptide antibiotic that binds to the bacterial cell wall. It is used for the treatment of infections caused by staphylococci and p. aeruginosa, which are resistant to other antibiotics. The drug binds to a specific site on the bacterial cell wall, forming a coordination complex with the peptidoglycan layer and making it easier for water molecules to penetrate the cell wall. This leads to increased rates of cell death by osmosis. Teicoplanin enhances the activity of other antibiotics against Gram-positive bacteria by preventing their binding to penicillin-binding proteins in the bacterial cell walls.

2,9-Bis(2-phenylethyl)anthraquinone (BPAQ) is a synthetic compound that is used as an fluorescent probe to study biological processes. BPAQ binds to peptides and inhibits their binding to the surface of cells. This property has been used in diagnostic tests for stenosis, infantum, and other conditions. BPAQ has also been shown to inhibit HIV-1 replication in human cells by binding to the HIV-1 envelope protein gp120 and blocking its interaction with CD4 receptors on host cells. The discovery of the antiviral activity of BPAQ was based on its ability to inhibit leishmania growth in animals.

Fmoc-D-Gln(Mtt)-OH is a chiral, homologous protonated amino acid that has been synthesized. The configuration of the proton has not yet been determined and postulated as either R or S. The reagent can be used to probe the configuration of the proton by determining its chemical shift in a series of experiments. This compound is synthesized from D-glucamine and Mtt, which are both commercially available compounds. Fmoc-D-Gln(Mtt)-OH is easily soluble in organic solvents, such as ethanol, methanol, and dichloromethane. It is also stable under acidic conditions.

Please enquire for more information about Abz-Amyloid beta/A4 Protein Precursor770 (708-715)-Lys(Dnp)-D-Arg-D-Arg-D-Arg amide trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Cyclo(-Asp(OMe)-Asp(OMe)) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Cortistatin-29 (human) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 including the price, delivery time and more detailed product information at the technical inquiry form on this page

1-(4-Hydroxy-3-methoxyphenyl)-2-nitroethene is an experimental molecule that was not previously known to exist. The intramolecular reaction of 1,4-dihydroxynitrobenzene and glyoxylic acid yields the product. It is a phenolic compound with biological activity, which has been shown to inhibit glycosidases and alkaloids.

Please enquire for more information about H-Thr(tBu)-pNA including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about DABCYL-(Asn670,Leu671)-Amyloid b/A4 Protein Precursor770 (661-675)-EDANS ammonium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (Thr28, Nle 31)-Cholecystokinin-33 (25-33) (sulfated) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Hymenistatin I is a cyclic peptide that is synthesized from the natural amino acid L-proline. It has been shown to inhibit tumor growth and is used in the treatment of bladder cancer. The synthesis of Hymenistatin I begins with the protection of proline as an N-tert-butyloxycarbonyl derivative, followed by a sequence of coupling reactions. This synthetic process involves the use of a linker, such as tetrazole or succinimidyl ester, for example. The final product can then be purified by HPLC analysis. Hymenistatin I inhibits calcineurin inhibitor, which are immunosuppressive agents that are used to treat lymphocytic leukemia and other autoimmune diseases.

Amyloid beta-protein (Aβ) is a protein that is involved in the metabolic processes that are thought to be associated with Alzheimer's disease. Aβ is a peptide of 39-43 residues and is found in amyloid plaques, which are aggregates of Aβ. The amino acid sequence of human Aβ has been determined by sequencing the cDNA and gene for this protein. The structure of the protein has been studied using molecular modeling, kinetic data, and predictive biomarker studies. Cleavage products have been identified from the protein, including beta-amyloid peptide (1-40), which can be used as a diagnostic marker for Alzheimer's disease. Structural analysis has also shown lysine residues that may serve as pharmaceutical targets for therapeutic intervention.

MeOSuc-Ala-Ala-Pro-Val-AMC is a serine protease inhibitor that has been shown to inhibit neutrophil elastase and human trypsin. It has been shown to be effective in the treatment of inflammatory diseases such as hepatitis, colitis, and Crohn's disease. MeOSuc-Ala-Ala-Pro-Val-AMC also inhibits coagulation and can be used as an anticoagulant. This drug is one of the few drugs that have been shown to inhibit both trypsin and elastase with equal potency.

Please enquire for more information about Fmoc-Asp(OtBu)-Wang resin (200-400 mesh) including the price, delivery time and more detailed product information at the technical inquiry form on this page